Legend Biotech Corp ADR (NASDAQ: LEGN) is -3.26% lower on its value in year-to-date trading and has touched a low of $27.34 and a high of $60.87 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LEGN stock was last observed hovering at around $30.36 in the last trading session, with the day’s gains setting it 1.12%.
Currently trading at $31.48, the stock is 6.61% and -0.68% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.24 million and changing 3.69% at the moment leaves the stock -19.47% off its SMA200. LEGN registered -21.36% loss for a year compared to 6-month loss of -27.31%. The firm has a 50-day simple moving average (SMA 50) of $31.6952 and a 200-day simple moving average (SMA200) of $39.088974.
The stock witnessed a 0.35% gain in the last 1 month and extending the period to 3 months gives it a -7.90%, and is 8.66% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.08% over the week and 3.97% over the month.
Legend Biotech Corp ADR (LEGN) has around 2609 employees, a market worth around $5.79B and $728.30M in sales. Fwd P/E is 52.44. Profit margin for the company is -29.95%. Distance from 52-week low is 15.14% and -48.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.86%).
with sales reaching $234.15M over the same period.The EPS is expected to grow by 12.62% this year, but quarterly earnings will post 63.21% year-over-year. Quarterly sales are estimated to grow 25.53% in year-over-year returns.
335.0 institutions hold shares in Legend Biotech Corp ADR (LEGN), with institutional investors hold 48.43% of the company’s shares. The shares outstanding are 184.03M, and float is at 181.38M with Short Float at 4.18%. Institutions hold 47.79% of the Float.
The top institutional shareholder in the company is FMR LLC with over 17.62 million shares valued at $$780.46 million. The investor’s holdings represent 9.6503 of the LEGN Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 11.49 million shares valued at $$508.86 million to account for 6.292 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.51 million shares representing 4.1111 and valued at over $$332.48 million, while HHLR ADVISORS, LTD. holds 3.6344 of the shares totaling 6.64 million with a market value of $$293.93 million.
Legend Biotech Corp ADR (LEGN) Insider Activity
Still, SEC filings show that on Mar 25 ’25, Huang Ying (Officer) Proposed Sale 4,064 shares at an average price of $35.28 for $0.14 million. The insider now directly holds shares of Legend Biotech Corp ADR (LEGN).
